1 Min Read
March 20 (Reuters) - Bioorganic Research and Services SA:
* Says United States patent office has granted a patent to its unit Zera Intein Protein (ZIP) Solutions for "Recombinant protein bodies as immunogenspecific adjuvants"
* This new patent covers the use and administration of DNA vaccines encoding fusions between Zera self-assembling sequences and any antigen for the stimulation of an immune response against the antigen in question Source text for Eikon: bit.ly/2ncUKME
Further company coverage: (Gdynia Newsroom)